Bausch Health Cos - 31 Year Stock Split History | BHC

Stock split history for Bausch Health Cos since 1994. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bausch Health Cos Annual Stock Splits
Bausch Health Cos Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.003B $9.625B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.357B 6.72
Dr Reddy's Laboratories (RDY) India $11.687B 22.29
BridgeBio Pharma (BBIO) United States $7.324B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.839B 17.10
Amphastar Pharmaceuticals (AMPH) United States $1.164B 7.04
Taysha Gene Therapies (TSHA) United States $0.529B 0.00
Personalis (PSNL) United States $0.367B 0.00
Assembly Biosciences (ASMB) United States $0.108B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00